These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 642581)
21. [Haemochron--a simple method of monitoring heparin level during extracorporeal circulation]. Saggau W; Lüllig H; Storch HH; Tanzeem A; Schmitz W; Hissen W Chir Forum Exp Klin Forsch; 1978; (1978):119-22. PubMed ID: 752575 [TBL] [Abstract][Full Text] [Related]
22. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation. Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370 [TBL] [Abstract][Full Text] [Related]
23. Use of activated clotting time to monitor anticoagulation during cardiac surgery. Niinikoski J; Laato M; Laaksonen V; Jalonen J; Inberg MV Scand J Thorac Cardiovasc Surg; 1984; 18(1):57-61. PubMed ID: 6609429 [TBL] [Abstract][Full Text] [Related]
24. [The risk of hemorrhaging in the prevention of thromboembolism in general surgery: comparison of low-dose heparin and heparin-dihydergot 2500]. Ammann JF; Aebi B Chirurg; 1983 Jan; 54(1):29-32. PubMed ID: 6851723 [TBL] [Abstract][Full Text] [Related]
25. [Hemorrhages during cardiac surgery with extracorporeal circulation]. Gascon P; Daussy M; Daumet P Ann Chir Thorac Cardiovasc; 1967 Jul; 6(3):323-7. PubMed ID: 5618385 [No Abstract] [Full Text] [Related]
26. [Present state of heparin therapy]. Blatrix C; Soulier JP; Vacheron A; Cornu P Presse Med (1893); 1969 Mar; 77(15):553-6. PubMed ID: 5796027 [No Abstract] [Full Text] [Related]
27. [Resuscitation of patients with high risk of hemorrhage and thromboembolism. Biological supervision. Indications of controlled heparin therapy]. Boneu B; Cathala B; Jorda MF; Bierme R; Lareng L Nouv Presse Med; 1972 Jan; 1(1):29-32. PubMed ID: 5061187 [No Abstract] [Full Text] [Related]
28. [Prevention of thromboembolism with heparin in gynecological and obstetric surgery]. Wagner KL; Kaiser M; Korte W; Etzel F Fortschr Med; 1977 Oct; 95(39):2403-6. PubMed ID: 914200 [TBL] [Abstract][Full Text] [Related]
29. [Attempted prevention of thromboembolic disease in cardiac surgery with calcium heparinate. Our experience]. Cella G; Russo R; Patrassi G; Schiavinato ML; Schivazappa L; Girolami A Boll Soc Ital Cardiol; 1977; 22(4):535-7. PubMed ID: 617297 [No Abstract] [Full Text] [Related]
30. [Use of activated coagulation time for controlling the heparinization level during operations with artificial circulation]. Dement'eva II; Savina ME; Piatnitskaia GKh Anesteziol Reanimatol; 1980 Aug; (4):29-32. PubMed ID: 7416544 [No Abstract] [Full Text] [Related]
31. Use of the activated coagulation time in cardiac surgery. Effects on heparin-protamine dosages and bleeding. Papaconstantinou C; Rådegran K Scand J Thorac Cardiovasc Surg; 1981; 15(2):213-5. PubMed ID: 7336191 [TBL] [Abstract][Full Text] [Related]
32. [Postoperative thromboembolism: preventive use of calcium heparin in low doses]. Di Laura I; Capellaro L; Giammarinaro A Minerva Med; 1985 Feb; 76(5):153-61. PubMed ID: 3974928 [TBL] [Abstract][Full Text] [Related]
33. [A computerized method for the administration of heparin and protamine during open-heart surgery]. Isshiki A; Sakaguchi Y; Kubota K; Ikeda T Masui; 1984 Dec; 33(12):1323-8. PubMed ID: 6530734 [No Abstract] [Full Text] [Related]
34. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients]. Zabolotskikh IB; Sin'kov SV; Klevko VA Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909 [No Abstract] [Full Text] [Related]
35. Anticoagulant monitoring and neutralization during open heart surgery--a rapid method for measuring heparin and calculating safe reduced protamine doses. Umlas J; Taff RH; Gauvin G; Swierk P Anesth Analg; 1983 Dec; 62(12):1095-9. PubMed ID: 6650893 [TBL] [Abstract][Full Text] [Related]
36. [Prevention of thromboembolism using subcutaneous heparin]. Saggau W; Encke A; Schmidt U Chirurg; 1974 Sep; 45(9):407-9. PubMed ID: 4425325 [No Abstract] [Full Text] [Related]
37. Subcutaneous low dose heparin in the prevention of postoperative thromboembolic complications. Kroese A; Dobloug I J Oslo City Hosp; 1976 Apr; 26(4):45-7. PubMed ID: 1263020 [No Abstract] [Full Text] [Related]
38. Prevention of postoperative thromboembolism in general surgery with enoxaparin. Samama MM Eur J Surg Suppl; 1994; (571):31-3. PubMed ID: 7519086 [No Abstract] [Full Text] [Related]
39. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot. Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293 [TBL] [Abstract][Full Text] [Related]
40. [Mini-doses of heparin in the endoscopic resection of the prostate]. Netto Júnior NR; Srulzon GB Rev Paul Med; 1983; 101(3):100-2. PubMed ID: 6606206 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]